MVs have gained much interest since it was determined that an elevated level of MVs can serve as a useful biomarker for clinical diagnosis of various diseases, including cardiovascular diseases, infectious diseases, and cancer. [9-13] Therefore, development of techniques for submicrometer MV isolation is desirable for quantification and downstream analyses in clinical applications. [14] Traditional methods currently used to isolate MVs include high-speed-or ultracentrifugation and immunoaffinity capture. [15,16] However, the ultracentrifugation process can create artefactual MVs due to the high shear stress exerted on cells and can create a size bias in the MV population. [14] In addition, the lack of a consensus protocol for centrifugation can limit the preparation of MVs. [15,17] Furthermore, the immunoaffinity capture method may negatively affect the integrity of MVs with the MVs losing their functionality after the elution process. [18] These limitations cause a need for the development of label-free techniques that would enable isolation of intact MPs without the use of high-speed centrifugation. According to recent studies, various lab-on-a-chip techniques based on microfluidics have been used for separating submicrometer MVs, such as filtration, [19] immunocapture, [20] inertial microfluidics, [18,21] deterministic lateral displacement, [22] and acoustic field. [14,23,24] Recently, viscoelastic non-Newtonian microfluidics has achieved considerable attention owing to intrinsic nonlinear elastic forces in pressure-driven flows of polymer solutions. [25,26] The nonuniform distribution of the first normal stress difference (N 1) can drive the suspended particles/ cells laterally depending on the size differences. This technique has been applied to particle/cell focusing [27-30] and size-based particle/cell separation. [31-36] Recently, to replace the conventional centrifugation method, blood plasma extraction using Dean-flow-coupled viscoelastic effect was demonstrated, [37] in which red blood cells (RBCs), white blood cells (WBCs), and even platelets were filtered for high purity (99.99%) plasma extraction. However, the throughput of the device was limited to 50 µL min −1 and nanosized particles in blood plasma had not been analyzed. Viscoelastic microfluidics has been relatively less used in the smaller particle size regime, such as submicrometer EVs, due to small elastic forces. More recently, viscoelastic size-dependent separation of exosomes from other EVs was demonstrated. [38] The exosomes were separated from Cell-derived microvesicles (MVs, also known as microparticles, MPs) are known as important biomarkers of various diseases including cardiovascular diseases, infectious diseases, and cancer. Development of techniques for blood cell removal and MV isolation is required for downstream analyses in biological and clinical applications. A sheathless, label-free, viscoelastic microfluidic device is proposed for the separation of submicrometer plateletderived MPs (PDMPs) from whole blood. Flow rate and cha...